Hoshi Iryo-Sanki Co (TSE:7634) EBIT: 円2,010 Mil (TTM As of Mar. 2026)


TSE:7634 Hoshi Iryo-Sanki Co Ltd TSE:7634
85 GF Score
Price 円4,900.00
GF Value 円4,733.91
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Hoshi Iryo-Sanki Co EBIT?

Hoshi Iryo-Sanki Co TSE:7634 85 EBIT is 円2,010 Mil as of Mar. 2026. GuruFocus rates TSE:7634 with a GF Score™ of 85/100 and a GF Value™ of 円4,733.91 (Fairly Valued). The stock has 2 warning signs investors should review.

Hoshi Iryo-Sanki Co's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was 円1,087 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,010 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hoshi Iryo-Sanki Co's annualized ROC % for the quarter that ended in Mar. 2026 was 10.98%. Hoshi Iryo-Sanki Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 31.92%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hoshi Iryo-Sanki Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 35.23%.


Hoshi Iryo-Sanki Co  (TSE:7634) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hoshi Iryo-Sanki Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2110.912 * ( 1 - 29.91% )/( (13113.672 + 13845.903)/ 2 )
=1479.5382208/13479.7875
=10.98 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=25389.372 - 2760.535 - ( 10793.473 - max(0, 4171.197 - 13686.362+10793.473))
=13113.672

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=26743.855 - 3018.424 - ( 11210.93 - max(0, 4546.395 - 14425.923+11210.93))
=13845.903

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Hoshi Iryo-Sanki Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2173.674/( ( (6726.712 + max(-1278.308, 0)) + (6894.853 + max(-662.865, 0)) )/ 2 )
=2173.674/( ( 6726.712 + 6894.853 )/ 2 )
=2173.674/6810.7825
=31.92 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2475.51 + 243.506 + 173.873) - (2760.535 + 0 + 1410.662)
=-1278.308

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2892.507 + 219.104 + 103.382) - (3018.424 + 0 + 859.434)
=-662.865

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hoshi Iryo-Sanki Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2009.539/5704.507
=35.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoshi Iryo-Sanki Co EBIT Related Terms


Hoshi Iryo-Sanki Co EBIT Historical Data

* Premium members only.

The historical data trend for Hoshi Iryo-Sanki Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hoshi Iryo-Sanki Co EBIT Chart

Hoshi Iryo-Sanki Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,631.08 1,797.63 2,050.65 2,069.14 2,009.54

Hoshi Iryo-Sanki Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,133.96 927.01 1,142.14 922.70 1,086.84

TSE:7634 vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Hoshi Iryo-Sanki Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoshi Iryo-Sanki Co EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hoshi Iryo-Sanki Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hoshi Iryo-Sanki Co's EV-to-EBIT falls into.


TSE:7634
85GF Score
Hoshi Iryo-Sanki Co Ltd TSE:7634
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hoshi Iryo-Sanki Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円2,010 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円2,010 Mil mean?
Hoshi Iryo-Sanki Co (TSE:7634) has a EBIT of 円2,010 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hoshi Iryo-Sanki Co.
Is Hoshi Iryo-Sanki Co's EBIT too high?
Hoshi Iryo-Sanki Co's current EBIT is 円2,010 Mil. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's EBIT compare to MCK and CAH?
Hoshi Iryo-Sanki Co's EBIT of 円2,010 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hoshi Iryo-Sanki Co. Hoshi Iryo-Sanki Co's current EBIT is 円2,010 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Fairly Valued. The stock's GF Value™ is 円4,733.91, compared to a current price of 円4,900.00 — trading 3.5% above its estimated fair value. The current EBIT is 円2,010 Mil. Hoshi Iryo-Sanki Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current EBIT is 円2,010 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?

Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued. The current stock price of 円4,900.00 is trading 3.5% above its estimated GF Value™ of 円4,733.91. GuruFocus considers Hoshi Iryo-Sanki Co to be Fairly Valued.

Key valuation signals for TSE:7634:

  • EBIT: 円2,010 Mil
  • GF Value™: 円4,733.91 vs. price of 円4,900.00 (3.5% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hoshi Iryo-Sanki Co Business Description

Address 7-11-18 Iriya, Adachi-ku, Tokyo, JPN, 121-0836
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
85GF Score

Get the complete analysis for TSE:7634

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,900.00
Price
円4,733.91
GF Value